Christopher P. Lowe, Chief Financial Officer & CBO at Anthera Pharmaceuticals Inc (ANTH), sold 19,600 shares at $7.93 ($137K) on 2011-08-02, disclosed to the SEC on 2011-08-04.
Scheduled sale ($137k) by Chief Financial Officer & CBO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.28 | 4,700 | $34K | 25.0% |
| 2 | $7.93 | 300 | $2K | 1.7% |
| 3 | $6.88 | 14,600 | $100K | 73.3% |
| Total | $6.99 avg | 19,600 | $137K | 100% |
| Filing → |
| CRTX | SELL | 2021-08-18 | $4.1M | — | Filing → |
| CRTX | SELL | 2021-06-30 | $2.2M | — | Filing → |
| VINC | BUY | 2021-06-30 | $126K | — | Filing → |